"The CNS Summit Innovation Index -A data-driven, neutral assessment of the digitization of the pharmaceutical industry - Digital Intent

PHARMA HEALTHCARE BIOTECH DIGITAL NEWS & VIEWS

Thursday, 30 November 2017

"The CNS Summit Innovation Index -A data-driven, neutral assessment of the digitization of the pharmaceutical industry


The CNS Summit has released the 2017 CNS Summit Innovation Index. It ranks life science companies based on publicly available information, with regards to three facets of innovation: Trial Optimization, Digital Advancement, and Innovative Partnerships. The Index is powered by pharma innovation specialists IDEA Pharma.
Key findings show the rise of Astra Zeneca, Boehringer Ingelheim, BMS, Celgene, and Bayer as emerging innovation leaders. The goal of the CNS Summit Innovation Index is to objectively assess investments made in innovation, encourage leadership in innovation, and allow companies to benchmark their innovation activities via an objective external source.

The CNS Summit, founded on the principles of Collaboration, Innovation, and Technology, is a community working collaboratively to shape the future of the life sciences.  The CNS Summit 2017 is taking place November 16th—19th, 2017 in Boca Raton, Florida. 

No comments:

Post a Comment